SCHEMBL26087474

SCHEMBL26087474

O=C1CC[C@@H](c2c(F)cc(N3CC(NC(=O)Nc4cccc(OC(F)F)c4)C3)cc2F)C(=O)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 2/20 0.42
▸ FPR1 P21462 2/20 0.39
▸ FPR2 P25090 2/20 0.39
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ CCNC P24863 2/20 0.38
▸ CDK8 P49336 2/20 0.38
▸ CXCR3 P49682 1/20 0.37
▸ PIK3R1 P27986 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ CCR3 P51677 2/20 0.37
▸ USP30 Q70CQ3 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ ADRA1D P25100 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435433 1.00 EPHX2 (0.42) EPHX2FPR1FPR2NPC1RAB9A
SCHEMBL30408943 1.00 EPHX2 (0.42) EPHX2FPR1FPR2NPC1RAB9A
SCHEMBL26435443 0.91 CXCR3 (0.47) EPHX2CXCR3
SCHEMBL26090150 0.90 EPHX2 (0.45) EPHX2NPC1RAB9ACCNCCDK8
SCHEMBL26090446 0.90 FPR2 (0.39) EPHX2FPR1FPR2CCNCCDK8
SCHEMBL30407826 0.90 EPHX2 (0.45) EPHX2NPC1RAB9ACCNCCDK8
SCHEMBL26435659 0.90 FPR2 (0.39) EPHX2FPR1FPR2CCNCCDK8
SCHEMBL26435439 0.90 EPHX2 (0.45) EPHX2NPC1RAB9ACCNCCDK8
SCHEMBL30407271 0.89 FPR1 (0.43) EPHX2FPR1FPR2RAB9ACCNC
SCHEMBL26087705 0.89 FPR1 (0.43) EPHX2FPR1FPR2RAB9ACCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069708-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 — — WO disclosed
Send feedback